<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Authors describe a case of drug interaction between <z:chebi fb="0" ids="2663">amiodarone</z:chebi> and <z:chebi fb="8" ids="10033">warfarin</z:chebi> in 66-year-old man with recurrent <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In spite of a relatively low dose of <z:chebi fb="8" ids="10033">warfarin</z:chebi>, prothrombin time became extremely prolonged and <z:mp ids='MP_0001914'>bleeding</z:mp> manifestations occurred </plain></SENT>
<SENT sid="2" pm="."><plain>Effects of the interaction persisted for a long time after the withdrawal of both drugs </plain></SENT>
<SENT sid="3" pm="."><plain>Various approaches to oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> reversal are discussed </plain></SENT>
<SENT sid="4" pm="."><plain>Pharmacokinetics of both drugs is explained, as well as the mechanism of their interaction through <z:chebi fb="0" ids="38559">cytochrome P450</z:chebi> inhibition in the liver </plain></SENT>
<SENT sid="5" pm="."><plain>Authors emphasize the great interindividual variability and long persistence of this interaction </plain></SENT>
<SENT sid="6" pm="."><plain>It is necessary to consider carefully the indication of using these drugs together and when the use is inevitable, it is recommended to lower the <z:chebi fb="8" ids="10033">warfarin</z:chebi> dose to 50-70% and to perform thorough and frequent INR monitoring </plain></SENT>
</text></document>